Pancreatectomy with arterial resection following neoadjuvant FOLFIRINOX: A single-institution experience
Arterial resection following neoadjuvant therapy in selected pancreatic cancer patients demonstrates acceptable perioperative risk and achieves survival outcomes comparable to less advanced cases. This approach is justified in experienced high-volume centers for appropriately selected patients with favorable response to neoadjuvant therapy, offering potential cure in rare circumstances.
Authors
- Nir Messer (ORCID: https://orcid.org/0000-0002-4686-9583)
- Guy Meyerovich (ORCID: https://orcid.org/0000-0003-0537-6317)
- Alexander Barenboim (ORCID: https://orcid.org/0000-0001-7839-9005)
- Mohammed T. Younis
- Esther Ovdat
- Nir Lubezky (ORCID: https://orcid.org/0000-0001-9355-4405)
- Fahim Kanani (ORCID: https://orcid.org/0009-0001-9754-5028)
- Yaacov Goykhman
Institutions
- Tel Aviv University (IL)
- Tel Aviv Sourasky Medical Center (IL)
Publication Details
- Journal
- Annals of Hepato-Biliary-Pancreatic Surgery
- Published
- 2025-07-24
- DOI
- https://doi.org/10.14701/ahbps.25-108
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00